Filippo Pietrantonio, MD, discusses findings from the phase 1/2 OrigAMI-1 study in RAS/BRAF wild-type mCRC.
Filippo Pietrantonio, MD
Advertisement
Filippo Pietrantonio, MD, is a medical oncologist at the National Cancer Insitute of Milan, Italy.
Articles by Filippo Pietrantonio, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets
2
Asundexian Cuts Recurrent Stroke Risk Without More Bleeding: Mukul Sharma, MD, MSc
3
Faricimab Safe, Effective for Use in Treating nAMD in Treatment-Naive Eyes
4
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
5